©The Author(s) 2022.
World J Virol. Sep 25, 2022; 11(5): 321-330
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.321
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.321
Table 4 Details of the clinical course of coronavirus disease 2019 in oncology patients
| Parameters | Number | Percentage |
| Presenting symptoms | ||
| Fever | 24 | 60 |
| Cough | 15 | 37.5 |
| Sore throat | 3 | 7.5 |
| Dyspnea | 2 | 5 |
| Diarrhea | 2 | 5 |
| Disease severity | ||
| Asymptomatic | 10 | 25 |
| Mild disease | 20 | 50 |
| Moderate disease | 8 | 20 |
| Severe disease | 2 | 5 |
| Place of care | ||
| Home isolation | 12 | 30 |
| COVID-19 ward | 26 | 65 |
| PICU | 2 | 5 |
| Treatment required | ||
| No treatment | 10 | 25 |
| IV antibiotic | 24 | 60 |
| Azithromycin | 30 | 75 |
| Vitamins | 30 | 75 |
| Dexamethasone | 26 | 65 |
| Oxygen support | 4 | 10 |
| CPAP | 2 | 5 |
| IVIG | 9 | 22.5 |
- Citation: Qatawneh MA, Altarawneh M, Alhazaimeh R, Jazazi M, Jarrah O, Shorman A, Alsadah L, Mustafa M. Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan. World J Virol 2022; 11(5): 321-330
- URL: https://www.wjgnet.com/2220-3249/full/v11/i5/321.htm
- DOI: https://dx.doi.org/10.5501/wjv.v11.i5.321